MDL 29913
MDL 29913, a cyclic pseudopeptide, is a competitive NK2 tachykinin receptor selective antagonist, with a pA2 of 8.66[1].
Product Specifications
CAS Number
135721-56-1
UNSPSC
12352209
Target
Neurokinin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/mdl-29913.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@H](C(NCC(NC(CN([C@H](C(N[C@H](C(N1)=O)CCC(N)=O)=O)CC(C)C)C)CC(C)C)=O)=O)CC2=CC=CC=C2)[C@@H]1CC3=CNC4=CC=CC=C34
Molecular Formula
C40H56N8O6
Molecular Weight
744.92
References & Citations
[1]C A Maggi, et al. MEN 10,573 and MEN 10,612, novel cyclic pseudopeptides which are potent tachykinin NK-2 receptor antagonists. Regul Pept. 1993 Sep 3;47 (2) :151-8.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP234736 200 Reactions
ZNF562 Human qPCR Primer Pair (NM_001130031)
Sign In for Pricing
View Details 
![PTP1B Recombinant Rabbit Monoclonal Antibody [JJ0935]](https://cdn.genprice.uk/products/992/68dd1c90061270361ea82938/imageurl/et1701-90.webp)
ET1701-90 100 µL
PTP1B Recombinant Rabbit Monoclonal Antibody [JJ0935]
Sign In for Pricing
View Details 
BNC942808-100 1x 100 µL
Cytokeratin 18 (KRT18) (KRT18/2808R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details